Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1

Nature Genetics

Volumn 32, Issue 2, 2002, Pages 245-253

  Nakae, Jun ^a   Biggs III, William H ^b   Kitamura, Tadahiro ^a   Cavenee, Webster K ^b   Wright, Christopher V E ^c   Arden, Karen C ^b   Accili, Domenico ^a  

^a The New York Presbyterian Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ISOLATION; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIVER; MICE; MICE, TRANSGENIC; MUTATION; ORGAN SPECIFICITY; RECEPTOR, INSULIN; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036787607     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng890     Document Type: Article

References (40)

1. National Diabetes Data Group. Diabetes in America (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, 1995).
2. Saltiel, A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517-529 (2001).
3. Taylor, S.I., Accili, D. & Imai, Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43, 735-740 (1994).
4. Bergman, R.N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus, Trends Endocrinol. Metab. 11, 351-356 (2000).
5. Hotamisligil, G.S. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int. J. Obes, Retat. Metab. Disord. 24 (Suppl. 4), S23-S27 (2000).
6. Michael, M.D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97 (2000).
7. Rother, K.I. et al. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol, Chem. 273, 17491-17497 (1998).
8. Withers, D.J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904 (1998).
9. Kulkarni, R.N. et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329-339 (1999).
10. Kulkarni, R.N. et al. Altered function of insulin receptor substrate-1 -deficient mouse islets and cultured β-cell lines. J. Clin. Invest. 104, R69-75 (1999).
11. Kubota, N. et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49, 1880-1889 (2000).
12. Nakae, J., Kido, Y. & Accili, D. Tissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice. Ann. Med. 33, 22-27 (2001).
13. Kaestner, K.H., Knochel, W. & Martinez, D.E, Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14, 142-146 (2000).
14. Lin, K., Dorman, J.B., Rodan, A. & Kenyon, C. Daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans, Science 278, 1319-1322 (1997).
15. Ogg, S. et al. The Forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C elegans. Nature 389, 994-999 (1997).
16. Apfeld, J. & Kenyon, C. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95, 199-210 (1998).
17. Lin, K., Hsin, H., Libina, N. & Kenyon, C,. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nature Genet. 28, 139-145 (2001).
18. Accili, D. et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet. 12, 106-109 (1996).
19. Nakae, J., Park, B.-C. & Accili, D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982-15985 (1999).
20. Anderson, M.J., Viars, C.S., Czekay, S., Cavenee, W.K. & Arden, K.C. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47, 187-199 (1998).
21. Nasrin, N. et al. DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc. Natl Acad. Sci. USA 97, 10412-10417 (2000).
22. Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561-572 (1997).
23. Kido, Y., Philippe, N., Schaeffer, A.A. & Accili, D. Genetic modifiers of the insulin resistance phenotype. Diabetes 49, 589-596 (2000).
24. Kido, Y. et al. Tissue-specific insulin resistance in mice with combined mutations of Insulin Receptor, IRS-1 and IRS-2. J. Clin. Invest. 105, 199-205 (2000).
25. Shen, W., Scearce, L.M., Brestelli, J.E., Sund, N.J. & Kaestner, K.H. Foxa3 (Hepatocyte Nuclear Factor 3γ) is required for the regulation of hepatic glut2 expression and the maintenance of glucose homeostasis during a prolonged fast. J. Biol. Chem. 276, 42812-42817 (2001).
26. Nakae, J., Kitamura, T., Biggs, W., Arden, K. & Accili, D. The forkhead transcription factor FKHR inhibits adipocyte differentiation. Diabetes 50 (Suppl. 2), A22 (2001).
27. Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927 (1999).
28. Nakae, J., Barr, V. & Accili, D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR, EMBO J. 19, 989-996 (2000).
29. Yan, C., Costa, R.H., Darnell, J.E., Jr., Chen, J.D. & Van Dyke, T.A. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869-878 (1990).
30. Allen-Jennings, A.E., Hartman, M.G., Kociba, G.J. & Hai, T. The roles of atf3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J. Biol. Chem. 276, 29507-29514 (2001).
31. Jacobsson, B. et al. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J. Histochem. Cytochem. 37, 31-37 (1989).
32. Cherrington, A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48, 1198-1214 (1999).
33. Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97, 7999-8004 (2000).
34. Bouwens, L. & Pipeleers, D.G. Extra-insular β cells associated with ductules are frequent in adult human pancreas. Diabetologia 41, 629-633 (1998).
35. Sharma, A. et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48, 507-513 (1999).
36. Nakae, J., Kitamura, T., Silver, D.L. & Accili, D. The forkhead transcription factor Foxol (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367 (2001).
37. Kitamura, T. et al. The transcription factor FKHR regulates pancreatic β cell survival. Diabetes 50 (Suppl. 2), A345 (2001).
38. Kadowaki, T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 106, 459-465 (2000).
39. Bonner-Weir, S. Life and death of the pancreatic β cells. Trends Endocrinol Metab. 11, 375-378 (2000).
40. Kitamura, T. et al. Preserved pancreatic β-cell development and function in mice lacking the insulin receptor-related receptor. Mol. Cell. Biol. 21, 5624-5630 (2001).